Achieve Life Sciences, Inc. (ACHV) stock

ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30

$6.72+0.34 (+5.33%)

Close on Nov 6, 2026Market cap $708.81MP/E –Yield –

Achieve Life Sciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Achieve Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?